Advanced search

Mr. Rolf A. Classon is a Chairman at Perrigo Co. Plc, an Operating Partner at Five Arrows Managers (USA) LLC, an Independent Director at Catalent, Inc., a Vice Chairman-Supervisory Board at Fresenius Medical Care AG & Co. KGaA, a Chairman at Lappesands Invest AB, a Chairman at QleanAir Scandinavia AB and a Senior Advisor at Brown Brothers Harriman Capital Partners. He is on the Board of Directors at Catalent, Inc., Fresenius Medical Care AG & Co. KGaA, Prometheus RxDx, Inc., Eurand NV, Destination Pet LLC and Fresenius Medical Care Management AG. Mr. Classon was previously employed as a Chairman by Sequana Medical AG, an Independent Director by Medivir AB, a Chairman by QleanAir Holding AB, a Chairman by EKR Therapeutics, Inc., a Chairman by Aerocrine AB, a Chairman by Tecan Group AG, a Chairman by Xanodyne Pharmaceuticals, Inc., a Chairman by Swedish Orphan International Holding AB, a Chairman by Hill-Rom AB, a Non-Executive Chairman by Auxilium Pharmaceuticals LLC, a Chairman by Protedyne Corp., a Chairman by Hill-Rom Holdings, Inc., a Chairman & Chief Executive Officer by Bayer HealthCare AG, a Chief Executive Officer by Bayer Healthcare LLC, an Executive Vice President by Bayer Corp., a President by Bayer Diagnostics Corp., a President & Chief Operating Officer by Pharmacia Biosystems AB, a President by Pharmacia Development Co., Inc., a President by Pharmacia AB, a Director-Organization Development by Pharmacia AB, a Chairman by Attana AB, a Chairman-Supervisory Board by Bayer AG, an Operating Partner by Health Evolution Management Co. LLC, and a Chairman by Vivacta Ltd. He also served on the board at Pharmanet Development Group, Inc., Millipore Corp., ISTA Pharmaceuticals, Inc., Prometheus Laboratories, Inc., Enzon Pharmaceuticals, Inc. and Eurand SpA. He received his graduate degree from the University of Gothenburg.

Malin Classon currently holds the position of Chief Executive Officer at Värnamo Energi AB.

Brendan Classon worked as a Director of Pharmacology at Regeneron Pharmaceuticals, Inc., a Director of Biopharmaceuticals Innovation Sourcing at Novo Nordisk A, and a Vice President of Research at Kiniksa Pharmaceuticals Ltd.
He holds a doctorate degree from the University of Melbourne and an undergraduate degree from Monash University.